 | Up a level |
Schmid, S; Jochum, W; Padberg, B; Demmer, I; Mertz, K D; Joerger, M; Britschgi, C; Matter, M S; Rothschild, S I; Omlin, A (2022). How to read a next-generation sequencing report-what oncologists need to know. ESMO open, 7(5), p. 100570. BMJ 10.1016/j.esmoop.2022.100570
Koelzer, V H; Herzig, P; Zlobec, Inti; Heinzelmann, V; Lardinois, D; Walseng, E; Rader, C; Mertz, K D; Zippelius, A; Thommen, D S (2021). Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform. Immuno-oncology technology, 10(C) Elsevier 10.1016/j.iotech.2021.100034
Koelzer, V H; Glatz, K; Bubendorf, L; Weber, A; Gaspert, A; Cathomas, G; Lugli, Alessandro; Zippelius, A; Kempf, W; Mertz, K D (2017). [The pathology of adverse events with immune checkpoint inhibitors]. Der Pathologe, 38(3), pp. 197-208. Springer 10.1007/s00292-017-0281-1
Mertz, K D; Schmid, M; Burger, B; Itin, P; Palmedo, G; Schärer, L; Kutzner, H; Fernández Figueras, M T; Cribier, B; Pfaltz, M; Kempf, W (2011). Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms. Dermatology, 222(1), pp. 87-92. Basel: Karger 10.1159/000321880
